BusinessElto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive ImpairmentBy Nasdaq OMXMay 1, 2018, 2:31 PM UTC
BusinessAlzheimer’s Virtual Reality Sensory Experience Featured at Upcoming ASA WorkshopBy Nasdaq OMXMar 23, 2018, 1:31 PM UTC
BusinessStudy Shows First Practical Intervention For ChemobrainBy Nasdaq OMXOct 31, 2016, 8:00 PM UTC
